» Articles » PMID: 25672318

Clinical and Demographic Profile of Chromoblastomycosis in a Referral Service in the Midwest of São Paulo State (Brazil)

Overview
Specialty Dermatology
Date 2015 Feb 13
PMID 25672318
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Chromoblastomycosis is one of the most frequent deep mycoses found in rural populations. This cross-sectional, retrospective and descriptive study was conducted with cases of chromoblastomycosis diagnosed throughout 20 years. A higher prevalence was observed among White male rural workers, with an average age of 59.69 years. Median time between onset of symptoms and diagnosis was 156 months. Lesions were predominantly located on the lower limbs; 34% of cases reported previous trauma. The most common associated symptoms were itching, pain and burning sensation. Mycological examination was positive in 91% of cases and Fonsecaea pedrosoi was the most prevalent etiologic agent.

Citing Articles

Chromoblastomycosis: A case series from Eastern China.

Liu S, Zhi H, Shen H, Lv W, Sang B, Li Q PLoS Negl Trop Dis. 2022; 16(9):e0010800.

PMID: 36155495 PMC: 9536625. DOI: 10.1371/journal.pntd.0010800.


New possibilities for chromoblastomycosis and phaeohyphomycosis treatment: identification of two compounds from the MMV Pathogen Box® that present synergism with itraconazole.

Coelho R, Alves G, Figueiredo-Carvalho M, Almeida-Silva F, de Souza G, da Silva Lourenco M Mem Inst Oswaldo Cruz. 2022; 117:e220089.

PMID: 36102413 PMC: 9467274. DOI: 10.1590/0074-02760220089.


Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.

Guevara A, Nery A, de Souza Carvalho Melhem M, Bonfietti L, Rodrigues A, Hagen F Mycoses. 2022; 65(12):1146-1158.

PMID: 35869803 PMC: 9828117. DOI: 10.1111/myc.13505.


Social, environmental and microbiologic aspects of endemic mycoses in Brazil.

Costa M, Pereira de Sa N, Johann S, Santos D New Microbes New Infect. 2019; 29:100496.

PMID: 30949344 PMC: 6430732. DOI: 10.1016/j.nmni.2018.11.004.


Final diagnosis of 86 cases included in differential diagnosis of American tegumentary leishmaniasis in a Brazilian sample: a retrospective cross-sectional study.

Tirelli F, Vernal S, Roselino A An Bras Dermatol. 2017; 92(5):642-648.

PMID: 29166500 PMC: 5674696. DOI: 10.1590/abd1806-4841.20175794.


References
1.
Martinez R, Mendez Tovar L . Chromoblastomycosis. Clin Dermatol. 2007; 25(2):188-94. DOI: 10.1016/j.clindermatol.2006.05.007. View

2.
Queiroz-Telles F, Esterre P, Perez-Blanco M, Vitale R, Salgado C, Bonifaz A . Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment. Med Mycol. 2008; 47(1):3-15. DOI: 10.1080/13693780802538001. View

3.
Ameen M . Chromoblastomycosis: clinical presentation and management. Clin Exp Dermatol. 2009; 34(8):849-54. DOI: 10.1111/j.1365-2230.2009.03415.x. View

4.
Correia R, Valente N, Criado P, Martins J . Chromoblastomycosis: study of 27 cases and review of medical literature. An Bras Dermatol. 2010; 85(4):448-54. DOI: 10.1590/s0365-05962010000400005. View

5.
Avelar-Pires C, Simoes-Quaresma J, Moraes-de Macedo G, Brasil-Xavier M, Cardoso-de Brito A . Revisiting the clinical and histopathological aspects of patients with chromoblastomycosis from the Brazilian Amazon region. Arch Med Res. 2013; 44(4):302-6. DOI: 10.1016/j.arcmed.2013.04.008. View